• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

OrbiMed Advisors

edit

OrbiMed is ahealthcare-dedicated investment firm, with approximately $5 billion in assets under management. OrbiMed’s investment advisory business was founded in 1989 with a vision to invest across the spectrum of healthcare companies: from private start-ups to large multinational companies. OrbiMed manages the Caduceus Private Investments series of venture capital funds and a family of public equity investment funds.

Recent Milestones

edit

• 
  OrbiMed Advisors invested in Natera. (5/1/13)
  Posted 5/2/13 at 6:36am via finsmes.com
• 
  OrbiMed Advisors invested in Treato. (4/23/13)
  Posted 4/23/13 at 11:05pm via prweb.com
• 
  OrbiMed Advisors invested in Glaukos. (2/7/13)
  Posted 2/7/13 at 8:17pm via dowjones.com
• 
  OrbiMed Advisors invested in CardiAQ Valve Technologies. (11/29/12)
  Posted 11/29/12 at 9:06pm via dowjones.com
• 
  OrbiMed Advisors invested in Cardioxyl Pharmaceuticals. (11/13/12)
  Posted 11/14/12 at 7:38pm via cardioxyl.com
• 
  OrbiMed Advisors invested in Ambit Biosciences. (11/6/12)
  Posted 11/7/12 at 3:16am via yahoo.com
• 
  OrbiMed Advisors invested in Principia BioPharma. (10/29/12)
  Posted 10/29/12 at 7:59pm via bizjournals.com
• 
  OrbiMed Advisors invested in Aragon Pharmaceuticals. (10/4/12)
  Posted 10/5/12 at 2:10am via prnewswire.com
• 
  OrbiMed Advisors invested in OmniGuide. (8/28/12)
  Posted 8/28/12 at 6:22pm via finsmes.com
• 
  OrbiMed Advisors invested in Whale Imaging. (8/23/12)
  Posted 8/23/12 at 7:24pm via dowjones.com
• 
  OrbiMed Advisors invested in Ornim Medical. (8/21/12)
  Posted 8/21/12 at 6:51pm via finsmes.com
• 
  OrbiMed Advisors invested in Intercept Pharmaceuticals. (8/10/12)
  Posted 8/10/12 at 8:17pm via finsmes.com
• 
  OrbiMed Advisors invested in Sonendo. (6/28/12)
  Posted 6/28/12 at 7:24pm via dowjones.com
• 
  OrbiMed Advisors invested in Igenica. (6/12/12)
  Posted 6/12/12 at 6:45pm via finsmes.com
• 
  OrbiMed Advisors invested in Good Start Genetics. (4/2/12)
  Posted 4/2/12 at 5:22pm via masshightech.com
• 
  OrbiMed Advisors invested in ViewRay. (3/13/12)
  Posted 3/13/12 at 6:47pm via finsmes.com

Investments

Videos

Sources

1. OrbiMed Advisors Raises $312M Toward New Venture Fund (fis.dowjones.com) [edit]
2. Gov't, Orbimed launch biomed fund (globes.co.il) [edit]
3. OrbiMed launches $600M fund for royalty, debt deals (fiercebiotech.com) [edit]
4. OrbiMed Closes First Israel Fund At $222M, Makes Investment (fis.dowjones.com) [edit]
5. Natera Completes $54.6M Financing (finsmes.com) [edit]
6. Treato Raises $14.5m from OrbiMed, New Leaf and Reed Elsevier (prweb.com) [edit]
7. Glaukos Spots $30M for Eyeball Stent, Doesn't Blink in Ivantis Rivalry (pevc.dowjones.com) [edit]
8. CardiAQ Raises $37.3M Series B Led by OrbiMed (pevc.dowjones.com) [edit]
9. Cardioxyl Pharmaceuticals Raises $28 Million in Series B Financing Led by OrbiMed Advisors (cardioxyl.com) [edit]
10. Ambit Biosciences Completes $50 Million Financing to Advance Lead Drug Candidate in Acute Myeloid Leukemia (finance.yahoo.com) [edit]
11. Principia Biopharma Secures $12.5M Second Tranche In Series A Financing, Expands Senior Management Team (bizjournals.com) [edit]
12. Aragon Pharmaceuticals Raises $50 Million in Series D Financing to Advance Promising Therapeutic Candidates for Hormone-Driven Cancers (prnewswire.com) [edit]
13. OmniGuide Closes $35M Financing (finsmes.com) [edit]
14. Whale Imaging Lands $8M First Round Led by OrbiMed Asia (pevc.dowjones.com) [edit]
15. Ornim Raises $20M in Series B Funding (finsmes.com) [edit]
16. Intercept Pharmaceuticals Completes $30M Series C Financing (finsmes.com) [edit]
17. Sonendo Raises $9.2M of $20M Round for Root-Canal Tool (pevc.dowjones.com) [edit]
18. Igenica Raises $33M in Series C Funding (finsmes.com) [edit]
19. Good Start Genetics lands $14M (masshightech.com) [edit]
20. ViewRay Closes $45M Series C Venture Capital Financing (finsmes.com) [edit]
21. Roka Bioscience Secures $47.5 Million in Series D Financing (prnewswire.com) [edit]
22. arGEN-X Closes €27.5M Series B Funding Round (finsmes.com) [edit]
23. Rempex Announces Series B Financing of up to $67.5 Million (rempexpharma.com) [edit]
24. DFINE Closes $25M Equity Financing (finsmes.com) [edit]
25. Arteaus Therapeutics Raises $18M in Funding (finsmes.com) [edit]
26. Cleave Biosciences Raises $42M in Series A Financing (finsmes.com) [edit]
27. MRI-guided radiotherapy firm ViewRay gets $10M in new funding (wraltechwire.com) [edit]
28. Vessix Vascular Completes $23M Series B Financing (finsmes.com) [edit]
29. Roka Bioscience Completes $20M Series C Equity Financing (finsmes.com) [edit]
30. AMBIT BIOSCIENCES COMPLETES $30 MILLION SERIES D-2 FINANCING (ambitbio.com) [edit]
31. Connecticut’s Biodel plans to raise $30M (masshightech.com) [edit]
32. Crown Bioscience Closes $28.8M Series C Financing Round (equityhelpdesk.com) [edit]
33. Brain clot protection co SMT raises $10.5m (globes.co.il) [edit]
34. Arsanis closes Series A financing for $10 million (news-medical.net) [edit]
35. Bonovo Orthopedics, Inc. Closes Series C Financing Led by OrbiMed Asia Partners (bonovo-ortho.com) [edit]
36. Anthera Pharmaceuticals Announces Pricing of $31.5 Million PIPE Financing (investor.anthera.com) [edit]
37. Eddingpharm (Cayman) Closes $24M Series B Funding (finsmes.com) [edit]
38. Relypsa Raises $70M in Series B Financing (finsmes.com) [edit]
39. Good Start Genetics, Inc. Raises $18 Million to Develop and Launch Sequencing‐Based Pre‐Pregnancy Genetic Screening Test (goodstartgenetics.com) [edit]
40. superDimension Raises $24.8 Million in Debt and Equity Financing (superdimension.com) [edit]
41. ViewRay Secures Series C Financing (viewray.com) [edit]
42. Complete Genomics, Inc. Announces Completion of $39 Million Series E Financing (completegenomics.com) [edit]
43. Cerenis Therapeutics raises EUR 40 million in series C financing (cerenis.com) [edit]
44. DFine raises $36.2M to repair spine fractures (deals.venturebeat.com) [edit]
45. Acceleron Pharma pulls in $8.4M financing (masshightech.com) [edit]
46. Igenica, Inc.: Series B $24M (onbiovc.com) [edit]
47. Aragon Pharma readies first cancer trial after $22M B round (fiercebiotech.com) [edit]
48. SELECTA CLOSES $15 MILLION SERIES C FINANCING (freshnews.com) [edit]
49. Adimab, Inc.: Series D $8.2M (onbiovc.com) [edit]
50. OrbiMed Makes First Indian Investment Through Pan Asia Fund (fis.dowjones.com) [edit]
51. PharmAbcine Closes USD $6 Million Series A Financing (bio-medicine.org) [edit]
52. Complete Genomics bags $45M round for sequencing (fiercebiotech.com) [edit]
53. Enobia Raises US$50M from Current Investors in Series C Financing (enobia.com) [edit]
54. Aragon Pharmaceuticals, Inc.: Series A $8M (onbiovc.com) [edit]
55. CeraPedics, Inc. Raises $15 Million (devicespace.com) [edit]
56. Singulex Closes $19 Million Financing Round (bio-medicine.org) [edit]
57. Adimab, Inc. Announces Series C Financing (adimab.com) [edit]
58. ARYx Therapeutics Inc. Announces $21.6 Million Private Placement (investors.aryx.com) [edit]
59. Biolex Therapeutics Completes $60 Million Series D Financing to Accelerate Development of Locteron® in Hepatitis C (mitsuiventures.com) [edit]
60. Innovative Spinal Technologies Jilted, Now Bankrupt, Source Says (xconomy.com) [edit]
61. Glaukos Adds $35 Million (equityhelpdesk.com) [edit]
62. InteKrin raises $18.5M for continued work on diabetes drug (deals.venturebeat.com) [edit]
63. SGX Pharmaceuticals raises $25 million: SGX Pharmaceuticals Inc. (thefreelibrary.com) [edit]
64. enobia.com [edit]
65. Agensys Raises $41 Million (agensys.com) [edit]
66. EDGAR [edit]
67. Biomarker-diagnostics developer Singulex validates $19M (venturebeat.com) [edit]
68. Sientra, device maker for plastic surgery, raises $85M (deals.venturebeat.com) [edit]
69. ChemoCentryx, autoimmune disease drug co., raises $29.84M (deals.venturebeat.com) [edit]
70. CeraPedics Closes $12.25M PE Financing (rnaventures.blogspot.com) [edit]
71. EDGAR [edit]
72. ChemoCentryx Completes Series C Financing (chemocentryx.com) [edit]
73. Acceleron Pharma Closes $30M Series B Financing (acceleronpharma.com) [edit]
74. MacroGenics Raises $45M in Series C Financing - Company to Advance Monoclonal Antibody Clinical Programs (macrogenics.com) [edit]
75. ARIUS Closes US$21.5 Million Financing (business.highbeam.com) [edit]
76. Amnis Closes Oversubscribed $11.25M Series C Round (integraventures.net) [edit]
77. Adiana, Inc. Reports Completion of $23 Million Financing. (allbusiness.com) [edit]
78. EDGAR [edit]
79. ChemoCentryx Raises $33 Million in Private Financing (chemocentryx.com) [edit]